Statins are a class of hypolipidemic drugs, and they are HMGCoA reductase inhibitors. Statins are pleiotropic; recent studies have suggested that they might have a potential for prevention and treatment of Parkinson disease. This paper reviews recent researches about the roles of statins in the prevention and therapy of Parkinson disease in the nearest few years.